{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:10:12Z","timestamp":1783923012779,"version":"3.55.0"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Early synaptic failure is widely considered a primary driver of cognitive decline in Alzheimer's disease (AD), and previous studies have suggested that dopaminergic signaling may contribute to hippocampal synaptic dysfunction. Among dopaminergic receptors, dopamine D3 receptors (D3Rs) have emerged as important modulators of synaptic plasticity and cognitive processes, but their role in AD-related synaptic impairment remains unclear. The aim of this study was to determine whether pharmacological blockade of D3Rs could restore memory deficits and hippocampal synaptic dysfunction in preclinical models of AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Behavioral studies, including novel object recognition (NOR), novel object location (NOL), and open-field tests, were performed to evaluate recognition memory, spatial memory, locomotor activity, and anxiety-related behavior in two mechanistically distinct mouse models of AD: triple-transgenic 3xTg-AD mice and \u03b17 nicotinic acetylcholine receptor knockout (\u03b17KO) mice. Electrophysiological recordings in hippocampal slices were used to assess AMPA\/NMDA ratio, basal synaptic transmission, and long-term potentiation (LTP). qPCR and western blot analyses were performed to evaluate hippocampal D3R mRNA and protein expression, respectively. Pharmacological treatments included the selective D3R antagonist NGB-2904 and cariprazine, a clinically approved antipsychotic with high affinity for D3Rs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Recognition and spatial memory deficits were rescued by NGB-2904 and cariprazine in both AD models, without affecting locomotor activity or anxiety-related behavior. No sex-dependent differences were observed in the behavioral response to treatment. Electrophysiological recordings revealed a reduced AMPA\/NMDA ratio and impaired LTP in both models, while basal synaptic transmission was selectively reduced in 3xTg-AD mice. D3R-targeting compounds restored synaptic transmission and plasticity. Inhibition of PKA prevented the rescue of LTP induced by D3R blockade, suggesting the involvement of the cAMP\/PKA signaling pathway. Both models displayed reduced hippocampal D3R mRNA expression and protein levels, suggesting that the residual population of D3Rs might represent a viable target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Together, these findings demonstrate that D3R-targeting compounds rescue synaptic plasticity and memory deficits in two mechanistically distinct AD models. These results support a role for dopaminergic signaling in early synaptic dysfunction and highlights D3R modulation as a relevant pathway for further investigation in AD-related cognitive impairment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1840697","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:33:17Z","timestamp":1783920797000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dopamine D3 receptor blockade restores hippocampal synaptic plasticity and rescues memory deficits in Alzheimer's disease mouse models"],"prefix":"10.3389","volume":"18","author":[{"given":"Maria Rosaria","family":"Tropea","sequence":"first","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania","place":["Catania, Italy"]},{"name":"Oasi Research Institute-IRCCS","place":["Troina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Aceto","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore","place":["Rome, Italy"]},{"name":"Fondazione Policlinico Universitario A. Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Carmela","family":"Trovato","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania","place":["Catania, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Nicitra","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania","place":["Catania, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Santuccio","sequence":"additional","affiliation":[{"name":"Oasi Research Institute-IRCCS","place":["Troina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Intili","sequence":"additional","affiliation":[{"name":"Oasi Research Institute-IRCCS","place":["Troina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"D'Ascenzo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Universit\u00e0 Cattolica del Sacro Cuore","place":["Rome, Italy"]},{"name":"Fondazione Policlinico Universitario A. Gemelli IRCCS","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Puzzo","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania","place":["Catania, Italy"]},{"name":"Oasi Research Institute-IRCCS","place":["Troina, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1113\/JP282962","article-title":"Activation of histamine type 2 receptors enhances intrinsic excitability of medium spiny neurons in the nucleus accumbens","volume":"600","author":"Aceto","year":"2022","journal-title":"J. Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2011.11.020","article-title":"Postsynaptic complexin controls AMPA receptor exocytosis during LTP","volume":"73","author":"Ahmad","year":"2012","journal-title":"Neuron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.neurobiolaging.2007.11.010","article-title":"Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease","volume":"30","author":"Ambr\u00e9e","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e12791","DOI":"10.1111\/acel.12791","article-title":"Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease","volume":"17","author":"Baglietto-Vargas","year":"2018","journal-title":"Aging Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"10721","DOI":"10.1523\/JNEUROSCI.6413-10.2011","article-title":"When is the hippocampus involved in recognition memory?","volume":"31","author":"Barker","year":"2011","journal-title":"J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00213-018-4857-0","article-title":"The effects of cariprazine and aripiprazole on PCP-induced deficits on attention assessed in the 5-choice serial reaction time task [Erratum in: Psychopharmacology (Berl). 2018 May;235(5):1621]","volume":"235","author":"Barnes","year":"2018","journal-title":"Psychopharmacology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-011-2422-1","article-title":"Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice","volume":"220","author":"Besson","year":"2012","journal-title":"Psychopharmacology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/biom15060762","article-title":"Role of 5-HT1A and 5-HT7 receptors in memory regulation and the importance of their coexpression: a systematic review","volume":"15","author":"Briones-Aranda","year":"2025","journal-title":"Biomolecules"},{"key":"B9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2147\/TCRM.S35137","article-title":"A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia","volume":"9","author":"Caccia","year":"2013","journal-title":"Ther. Clin. Risk Manag."},{"key":"B10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1017\/S109285291900083X","article-title":"The role of dopamine D3 receptors in the mechanism of action of cariprazine","volume":"25","author":"Calabrese","year":"2020","journal-title":"CNS Spectr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bcp.2015.07.015","article-title":"The effect of \u03b17 nicotinic receptor activation on glutamatergic transmission in the hippocampus","volume":"97","author":"Cheng","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/JAD-171018","article-title":"Volume and connectivity of the ventral tegmental area are linked to neurocognitive signatures of Alzheimer's disease in humans","volume":"63","author":"De Marco","year":"2018","journal-title":"J. Alzheimers. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11571-016-9383-3","article-title":"A model of cooperative effect of AMPA and NMDA receptors in glutamatergic synapses","volume":"10","author":"Di Maio","year":"2016","journal-title":"Cogn. Neurodyn."},{"key":"B14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/0361073X.2024.2377440","article-title":"AMPA receptors endocytosis inhibition attenuates cognition deficit via c-Fos\/BDNF signaling in amyloid \u03b2 neurotoxicity","volume":"51","author":"Eyvani","year":"2025","journal-title":"Exp. Aging Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/HRP.0000000000000411","article-title":"Cariprazine and cognition in patients with schizophrenia and bipolar disorder: a systematic review","volume":"32","author":"Garc\u00eda-Fern\u00e1ndez","year":"2024","journal-title":"Harv. Rev. Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/cercor\/bhh202","article-title":"Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention","volume":"15","author":"Glickstein","year":"2005","journal-title":"Cereb. Cortex"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00210-012-0806-3","article-title":"Dopamine D3 receptor antagonism\u2013still a therapeutic option for the treatment of schizophrenia","volume":"386","author":"Gross","year":"2013","journal-title":"Naunyn Schmiedebergs. Arch. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of amyloid-\u03b2 and Tau proteins in Alzheimer's disease: confuting the amyloid cascade [Erratum in: J Alzheimers Dis. 2019 68:415]","volume":"64","author":"Gulisano","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1523\/JNEUROSCI.0163-19.2019","article-title":"Neuromodulatory action of picomolar extracellular A\u03b242 oligomers on presynaptic and postsynaptic mechanisms underlying synaptic function and memory","volume":"39","author":"Gulisano","year":"2019","journal-title":"J. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1101\/lm.026070.112","article-title":"Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease","volume":"19","author":"Guzm\u00e1n-Ramos","year":"2012","journal-title":"Learn. Mem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.neuint.2011.07.002","article-title":"Cariprazine (RGH-188), a potent D3\/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents","volume":"59","author":"Gyerty\u00e1n","year":"2011","journal-title":"Neurochem. Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/cne.10525","article-title":"Neuron-specific age-related decreases in dopamine receptor subtype mRNAs","volume":"456","author":"Hemby","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrn.2016.37","article-title":"Synaptic AMPA receptor composition in development, plasticity and disease","volume":"17","author":"Henley","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.neuron.2006.10.035","article-title":"AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss","volume":"52","author":"Hsieh","year":"2006","journal-title":"Neuron"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1074\/jbc.M110.177790","article-title":"Activation of D1\/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers","volume":"286","author":"J\u00fcrgensen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1460-9568.2003.02716.x","article-title":"Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease","volume":"18","author":"Kemppainen","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.109.160432","article-title":"Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)\/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile","volume":"333","author":"Kiss","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.brainres.2006.10.049","article-title":"Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain","volume":"1131","author":"Kumar","year":"2007","journal-title":"Brain Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"102031","DOI":"10.1016\/j.pneurobio.2021.102031","article-title":"Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's disease","volume":"202","author":"La Barbera","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00213-004-2096-z","article-title":"Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats","volume":"179","author":"Laszy","year":"2005","journal-title":"Psychopharmacology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/nprot.2013.155","article-title":"Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat. Protoc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41380-019-0511-4","article-title":"The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans","volume":"26","author":"Leggio","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.euroneuro.2008.07.012","article-title":"Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists","volume":"19","author":"Loiseau","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1471-4159.2006.04262.x","article-title":"Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis","volume":"100","author":"Millan","year":"2007","journal-title":"J. Neurochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1124\/jpet.107.134536","article-title":"S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects","volume":"324","author":"Millan","year":"2008","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e076268","DOI":"10.1136\/bmj-2023-076268","article-title":"Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study","volume":"385","author":"Mok","year":"2024","journal-title":"BMJ"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e70097","DOI":"10.1111\/psyg.70097","article-title":"Dopamine system dysfunction in Alzheimer's disease","volume":"25","author":"Moreira","year":"2025","journal-title":"Psychogeriatrics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.euroneuro.2013.05.006","article-title":"The potential role of dopamine D3 receptor neurotransmission in cognition","volume":"23","author":"Nakajima","year":"2013","journal-title":"Eur. Neuropsychopharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.euroneuro.2015.11.016","article-title":"Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology","volume":"26","author":"Neill","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"B44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/JAD-151159","article-title":"Salidroside a bioactive compound of Rhodiola Rosea, Ameliorates memory and emotional behavior in adult mice","volume":"52","author":"Palmeri","year":"2016","journal-title":"J. Alzheimers. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","article-title":"Dopamine and dopamine receptors in Alzheimer's disease: a systematic review and network meta-analysis","volume":"11","author":"Pan","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.brainresrev.2011.01.003","article-title":"Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease","volume":"67","author":"Penzes","year":"2011","journal-title":"Brain Res. Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.npp.1301103","article-title":"Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release","volume":"32","author":"Quarta","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"12893","DOI":"10.1523\/JNEUROSCI.1201-14.2014","article-title":"Intracellular accumulation of amyloid-\u03b2 (A\u03b2) protein plays a major role in A\u03b2-induced alterations of glutamatergic synaptic transmission and plasticity","volume":"34","author":"Ripoli","year":"2014","journal-title":"J. Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jalz.2014.10.011","article-title":"Alzheimer's Disease neuroimaging initiative (ADNI). Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion","volume":"11","author":"Roussotte","year":"2015","journal-title":"Alzheimers Dement"},{"key":"B50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13195-021-00925-1","article-title":"In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases","volume":"13","author":"Sala","year":"2021","journal-title":"Alzheimers. Res. Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/ADR-200191","article-title":"Phosphodiesterase inhibitors for Alzheimer's disease: a systematic review of clinical trials and epidemiology with a mechanistic rationale","volume":"4","author":"Sanders","year":"2020","journal-title":"J. Alzheimers Dis Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3233\/JAD-210171","article-title":"Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to Alzheimer's disease: implications for treatment","volume":"82","author":"Serra","year":"2021","journal-title":"J. Alzheimers. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-2999(97)01235-1","article-title":"Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat","volume":"336","author":"Sigala","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00210-012-0797-0","article-title":"Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia","volume":"386","author":"Sokoloff","year":"2013","journal-title":"Naunyn Schmiedebergs. Arch. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/s41380-024-02408-9","article-title":"Dopamine neuron degeneration in the ventral tegmental area causes hippocampal hyperexcitability in experimental Alzheimer's Disease","volume":"29","author":"Spoleti","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1017\/S1092852917000608","article-title":"Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes","volume":"22","author":"Stahl","year":"2017","journal-title":"CNS Spectr."},{"key":"B58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/7854_2022_326","article-title":"Dopamine D3 receptor, cognition and cognitive dysfunctions in neuropsychiatric disorders: from the bench to the bedside","volume":"60","author":"Torrisi","year":"2023","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"108072","DOI":"10.1016\/j.phrs.2025.108072","article-title":"Functional, synaptoproteomic and structural adaptations underlying sex-dependent traumatic stress susceptibility\/resilience in the hippocampus","volume":"223","author":"Torrisi","year":"2026","journal-title":"Pharmacol. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"102154","DOI":"10.1016\/j.pneurobio.2021.102154","article-title":"Genetic deletion of \u03b17 nicotinic acetylcholine receptors induces an age-dependent Alzheimer's disease-like pathology","volume":"206","author":"Tropea","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e14291","DOI":"10.1111\/acel.14291","article-title":"Blockade of dopamine D3 receptors improves hippocampal synaptic function and rescues age-related cognitive phenotype","volume":"23","author":"Tropea","year":"2024","journal-title":"Aging Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3233\/JAD-215209","article-title":"Innate preferences affect results of object recognition task in wild type and Alzheimer's disease mouse models","volume":"85","author":"Tropea","year":"2022","journal-title":"J. Alzheimers. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnsyn.2016.00030","article-title":"Loss of catecholaminergic neuromodulation of persistent forms of hippocampal synaptic plasticity with increasing age","volume":"8","author":"Twarkowski","year":"2016","journal-title":"Front. Synaptic Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0014-2999(97)00075-7","article-title":"Effects of the dopamine D3 receptor agonist, R(+)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin, on memory processes in mice","volume":"324","author":"Ukai","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature08488","article-title":"Sleep deprivation impairs cAMP signalling in the hippocampus","volume":"461","author":"Vecsey","year":"2009","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","first-page":"13217","DOI":"10.1073\/pnas.172504199","article-title":"Amyloid beta -peptide inhibition of the PKA\/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling","volume":"99","author":"Vitolo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"B67","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/npp.2011.254","article-title":"Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex","volume":"37","author":"Watson","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.neuroscience.2010.06.034","article-title":"Dopamine D1 but not D3 receptor is critical for spatial learning and related signaling in the hippocampus","volume":"169","author":"Xing","year":"2010","journal-title":"Neuroscience"},{"key":"B69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2016.01.008","article-title":"Dopamine agonists rescue A\u03b2-induced LTP impairment by Src-family tyrosine kinases","volume":"40","author":"Yuan Xiang","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.4103\/NRR.NRR-D-24-00230","article-title":"The dopaminergic system and Alzheimer's disease","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regen Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"14748","DOI":"10.3390\/ijerph192214748","article-title":"Evaluation of the effect of cariprazine on memory and cognition in experimental rodent models","volume":"19","author":"Zlatanova","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1840697\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:33:19Z","timestamp":1783920799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1840697\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":71,"alternative-id":["10.3389\/fnagi.2026.1840697"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1840697","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"article-number":"1840697"}}